Is Emmaus Life Sciences, Inc. (EMMA) a Buy, Sell, or Hold?
OTC : EMMA
Emmaus Life Sciences, Inc.
$0.0114 USD
$0.0 (-0.52%)
- Volume
- 10K
- Average Volume
- 50.11K
- Market Capitalization
- $800.15K
- P/E Ratio
- -0.09
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.02
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.08
| Source | Headline |
|---|---|
|
Emmaus Life Sciences Reports Quarterly Financial Results
Emmaus Life Sciences, Inc. (OTCQB: EMMA),a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its gurufocus.com - 2026-05-15 16:00:00 |
|
Emmaus Life Sciences Reports Quarterly Financial Results
TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2026. Highlights “We realized an 18% decline in net revenues for three month ended March 31, 2026 as compared to the same period in 2025 primarily driven by a 33% decrease in U.S. sales amid ongoing competition. businesswire.com - 2026-05-15 15:51:00 |
